[Federal Register: December 24, 2003 (Volume 68, Number 247)]
[Notices]               
[Page 74584-74589]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24de03-88]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Public Health Conference Support Cooperative Agreement Program 
for Human Immunodeficiency Virus Prevention

    Announcement Type: New.
    Funding Opportunity Number: 04039.
    Catalog of Federal Domestic Assistance Number: 93.941.
    Key Dates:
    Letter of Intent (LOI) Deadline: For conferences between the dates 
of April 1, 2004 to September 30, 2004, submit LOI on or before January 
19, 2004.
    Application Deadline: March 3, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under the Public Health 
Service Act, section 301(a), 42 U.S.C. 241(a), as amended and

[[Page 74585]]

section 317(a), 42 U.S.C. 247b(a), as amended.

    Purpose: The purpose of this program is to provide partial support 
for specific non-federal conferences in the areas of health promotion 
and disease prevention information/education programs. Conference 
support by CDC creates the appearance of CDC co-sponsorship; therefore, 
CDC will actively participate in the development and approval of those 
portions of the agenda supported by CDC funds. In addition, CDC 
reserves the right to approve or reject the content of the full agenda, 
press events, promotional materials (including press releases), speaker 
selection, and site selection. CDC funds will not be used for portions 
of meetings that are not approved. This program addresses the ``Healthy 
People 2010'' focus area of HIV, and the New Initiative: Advancing HIV 
Prevention.
    Measurable outcomes of the program will be in alignment with one or 
more of the following performance goals for the National Center for 
HIV, STD and TB Prevention (NCHSTP): Strengthen the capacity of our HIV 
prevention partners nationwide to monitor the HIV epidemic, develop and 
implement effective HIV prevention interventions, and evaluate 
prevention programs.
    Activities:
    Awardee activities for this program are as follows: a. Manage all 
activities related to conference content (e.g., objectives, topics, 
session design, workshops, special exhibits, speakers, fees, agenda 
composition, printing). Many of these items may be developed in concert 
with CDC personnel assigned to support the conference.
    b. Provide draft copies of the agenda, objectives, and proposed 
related activities to the CDC Project Official for review and comment. 
Submit a copy of the final agenda, objectives, and proposed related 
activities to the CDC Grants Management Office for approval.
    c. Determine and manage all promotional activities (e.g., title, 
logo, announcements, mailers, press). CDC must review and approve the 
use of any materials with reference to CDC involvement or support.
    d. Manage all registration processes with participants and 
registrants (e.g., travel, reservations, correspondence, conference 
materials and hand-outs, badges, and registration procedures).
    e. Plan, negotiate, and manage conference site arrangements, 
including all audiovisual needs.
    f. Develop the content and manage the activities of the conference.
    g. If the proposed conference is or includes a satellite broadcast, 
recipient will:
    (1) Provide individual, on-camera rehearsals for all presenters.
    (2) Provide at least one full dress rehearsal involving the 
moderator, all presenters, equipment, visuals, and practice telephone 
calls at least one day before the actual broadcast and as close to the 
actual broadcast time as possible.
    (3) Provide full scripting and Teleprompter use for the moderator 
and all presenters.
    h. Collaborate with CDC staff in reporting and disseminating 
conference results, recommendations, and relevant HIV prevention 
information. This information must be made available to appropriate 
Federal, State, and local agencies, healthcare providers, HIV/AIDS 
prevention and service organizations, and the general public.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    a. Provide technical assistance through telephone calls, 
correspondence, and site visits in the areas of program agenda 
development, implementation, and priority setting related to the 
cooperative agreement.
    b. Provide scientific collaboration for appropriate aspects of the 
program, including selection of speakers, pertinent scientific 
information on HIV, preventive measures, and program strategies for the 
prevention of HIV infection.
    c. Review draft agendas. The Grants Management Officer will approve 
or disapprove the final agenda and proposed related activities prior to 
release of restricted funds.
    d. Assist applicant in reporting and disseminating results, 
recommendations, and relevant HIV prevention information.

II. Award Information

    Type of Award: Cooperative Agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: $112,000.
    Approximate Number of Awards: Five.
    Approximate Average Award: $20,000.
    Floor of Award Range: $15,000.
    Ceiling of Award Range: $25,000.
    Anticipated Award Date: April 1, 2004.
    Budget Period Length: Six months.
    Project Period Length: Six months.
    Contingency awards will be made allowing usage of only 10 percent 
of the total amount to be awarded until a final full agenda, 
promotional materials (i.e., brochures, Save-the-Date, etc.), and 
evaluation questions are approved by CDC. Funding will be provided to 
support costs associated with preparation of the agenda. The remainder 
of funds will be released only upon CDC approval of the final and full 
agenda. CDC reserves the right to terminate co-sponsorship at any time.

III. Eligibility Information

III.1. Eligible Applicants

    Applications may be submitted by public and private nonprofit 
organizations and by governments and their agencies, such as:
    [sbull] Public nonprofit organizations
    [sbull] Private nonprofit organizations
    [sbull] Universities
    [sbull] Colleges
    [sbull] Technical Schools
    [sbull] Research institutions
    [sbull] Hospitals
    [sbull] Community-based organizations
    [sbull] Faith-based organizations
    [sbull] Federally recognized Indian tribal governments
    [sbull] Indian tribes
    [sbull] Indian tribal organizations
    [sbull] State and local governments or their Bona Fide Agents (this 
includes the District of Columbia, the Commonwealth of Puerto Rico, the 
Virgin Islands, the Commonwealth of the Northern Marianna Islands, 
American Samoa, Guam, the Federated States of Micronesia, the Republic 
of the Marshall Islands, and the Republic of Palau)
    A Bona Fide Agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state or local government as documentation of your status. Place this 
documentation behind the first page of your application form. Foreign 
organizations are not eligible to apply.

III.2. Cost Sharing or Matching

    Recipient financial participation is required for this program in 
accordance with this Program Announcement. CDC will not fund more than 
75 percent of the total cost of the conference. At least 25 percent of 
the cost for the conference must be supported with non-federal funds. 
This factor will be included as an evaluation criterion in the review 
of your application.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award

[[Page 74586]]

range, your application will be considered non-responsive and will not 
be entered into the review process. You will be notified that your 
application did not meet the submission requirements.
    If your application is incomplete or non-responsive to the 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1. Forms are available on the CDC Web site, at the following 
Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.

    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Letter of Intent (LOI):
    CDC requires that you send a LOI if you intend to apply for this 
program. Your LOI will be used as a pre-application mechanism. CDC will 
review and score your LOI. Only the high scoring LOIs will be invited 
to apply for funding. CDC will invite applicants to submit their full 
applications within 30 days after the LOI due date. Availability of 
funds may limit the number of applicants who receive an invitation to 
submit an application. Your LOI must be written in the following 
format:
    [sbull] Maximum number of pages: Two
    [sbull] Font size: 12-point unreduced
    [sbull] Paper size: 8.5 by 11 inches
    [sbull] Page margin size: One inch
    [sbull] Printed only on one side of page
    [sbull] Single-Spaced
    [sbull] Written in plain language, avoid jargon
    Your LOI must contain the following information:
    a. Name of organization.
    b. Mailing address.
    c. Telephone and fax numbers.
    d. E-mail address.
    e. Title of the proposed conference.
    f. Location of the proposed conference (city and state).
    g. Conference dates.
    h. Documented need for the conference.
    i. Purpose of the conference.
    j. Potential contribution to HIV/AIDS Prevention.
    k. Intended audience (number and description of conference 
attendees).
    l. Population(s) who that ultimately benefit from the information 
shared with conference attendees (population consists of persons at 
risk, i.e., women, men who have sex with men (MSM), injecting drug 
users and persons living with HIV).
    m. The estimated total cost of the conference.
    n. The percentage of the total cost (which must be 75 percent or 
less) being requested from CDC.
    o. The relationship of the conference to CDC's Funding Preferences, 
which are listed in section ``V.2 Review and Selection Process''.
    p. Potential contribution toward the National HIV prevention goals 
based on the CDC HIV Prevention Strategic Plan:
    1. Decrease new infections.
    2. Increase knowledge of serostatus.
    3. Increase linkage to prevention, care and treatment.
    4. Strengthen monitoring, capacity and evaluation.
    q. Potential contribution toward the New Initiative:
    Advancing HIV Prevention (See Attachment)
    1. Make voluntary testing a routine part of medical care.
    2. Implement new models for diagnosing HIV infections.
    3. Prevent new infections by working with persons diagnosed with 
HIV.
    4. Further decrease perinatal HIV transmission.
    Information on HIV prevention methods (or strategies) can include 
abstinence; monogamy, i.e., being faithful to a single sexual partner; 
or using condoms consistently and correctly. These approaches can avoid 
risk (abstinence) or effectively reduce risk for HIV Prevention 
(monogamy, consistent and correct condom use).
    If applicable, current recipients of CDC HIV funding must provide 
the award number and title of the funded programs.

    Note: No attachments, booklets, or other documents accompanying 
the LOI will be considered.

    Application:
    You must include a project narrative with your application forms. 
Your narrative must be submitted in the following format:
    [sbull] Maximum number of pages: 12 pages. If your narrative 
exceeds the page limit, only the first pages which are within the page 
limit will be reviewed.
    [sbull] Font size: 12-point unreduced.
    [sbull] Paper size: 8.5 by 11 inches.
    [sbull] Page margin size: One inch.
    [sbull] Double-spaced.
    [sbull] Printed only on one side of page.
    [sbull] Held together only by rubber bands or metal clips; not 
bound in any other way.
    [sbull] Written in plain language only. Do not use jargon or 
abbreviations.
    [sbull] Number all pages.
    [sbull] Include a complete index to the application and appendices.
    Your narrative should address activities to be conducted over the 
entire project period, and must include the following items in the 
order listed:
    a. A project summary cover sheet that includes:
    1. Name of organization.
    2. Name of conference.
    3. Location of conference.
    4. Date(s) of conference.
    5. Target population(s) who will benefit from the information 
shared with conference attendees (e.g., youth, women, men who have sex 
with men (MSM), injecting drug users and persons living with HIV).
    6. Intended audience (number and description of conference 
attendees).
    7. Define conference objectives.
    8. Dollar amount requested.
    9. Total conference budget.
    b. Biographical sketches and job descriptions of the individuals 
responsible for planning and coordinating the conference.
    c. A budget narrative separately identifying and justifying line 
items to which the requested Federal funds would be applied.
    d. A draft agenda for the proposed conference.
    e. Award number and title of funded programs for current recipients 
of CDC HIV funding. Applicants must have not submitted the same 
proposal for review for funding to other parts of CDC.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-

5711.

[[Page 74587]]

    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
 If your application form does not have a 

DUNS number field, please write your DUNS number at the top of the 
first page of your application, and/or include your DUNS number in your 
application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    For conferences during the dates of April 1, 2004 to September 30, 
2004.
    LOI Deadline Date: January 19, 2004.
    CDC requires that you send a LOI if you intend to apply for this 
program. Failure to submit a LOI precludes you from submitting an 
application.
    Application Deadline Date: March 3, 2004.
    Explanation of Deadlines: LOIs and Applications must be received in 
the CDC Procurement and Grants Office by 4 p.m. Eastern Time on the 
deadline date. If you send your LOI or application by the United States 
Postal Service or commercial delivery service, you must ensure that the 
carrier will be able to guarantee delivery of the application by the 
closing date and time. If CDC receives your LOI or application after 
closing due to: (1) carrier error, when the carrier accepted the 
package with a guarantee for delivery by the closing date and time, or 
(2) significant weather delays or natural disasters, you will be given 
the opportunity to submit documentation of the carriers guarantee. If 
the documentation verifies a carrier problem, CDC will consider the LOI 
or application as having been received by the deadline.
    This program announcement is the definitive guide on LOI and 
application submission and address. It supersedes information provided 
in the application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your LOI and your 
application. If you have a question about the receipt of your LOI or 
application, first contact your courier. If you still have a question, 
contact the PGO-TIM staff at: (770) 488-2700. Before calling, please 
wait two to three days after the application deadline. This will allow 
time for the LOIs and applications to be processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

IV.5. Funding Restrictions

    Funding restrictions, which must be taken into account while 
writing your budget are as follows:
    1. CDC funds will not be used for non-approved portions of 
meetings. CDC funds may be used for only those parts of the conference 
specifically supported by CDC as listed on the Notice of Cooperative 
Agreement Award. CDC funds may be used for direct costs, such as
    a. Salaries.
    b. Speaker fees.
    c. Rental of conference-related equipment.
    d. Registration fees.
    e. Scholarships.
    f. Transportation costs (not to exceed economy class fares) for 
non-federal employees.
    g. Mileage for local participants.
    2. CDC funds may not be used
    a. To purchase equipment.
    b. To pay honoraria.
    c. For organizational dues.
    d. To support entertainment.
    e. For personal expenses not related to the conference.
    f. For travel costs or payment to a Federal employee.
    g. For per diem and expenses for local participants.
    h. To reimburse indirect costs.
    i. To purchase novelty items (e.g., bags, T-shirts, hats, pens) 
distributed at meetings.
    j. To purchase food or drinks.
    3. CDC will not fund a conference after it has taken place.
    Contingency awards will be made allowing usage of only 10 percent 
of the total amount to be awarded until a final full agenda, 
promotional materials (i.e., brochures, Save-the-Date, etc.), and 
evaluation questions are approved by CDC. Funding will be provided to 
support costs associated with preparation of the agenda. The remainder 
of funds will be released only upon CDC approval of the final and full 
agenda. CDC reserves the right to terminate co-sponsorship at any time.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.


IV.6. Other Submission Requirements

    LOI Submission Address: Submit the original and two hard copies of 
your LOI by express mail or delivery service to: Technical Information 
Management--PA04039, Procurement and Grants Office, Centers for Disease 
Control and Prevention, 2920 Brandywine Rd., Atlanta, GA 30341-4146.
    LOIs may not be submitted electronically.
    Application Submission Address: Submit the original and two hard 
copies of your application by mail or express delivery service to: 
Technical Information Management--PA04039, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    Letter of Intent Criteria:
    The Letter of Intent will be evaluated against the following 
criteria:
    1. The extent to which the LOI content requirements are complete. 
Does the LOI address all the content requirements listed in Section IV: 
``Application and Submission Information?'' LOI must also address one 
or more of the elements listed in Section V. ``Application Review 
Information, Review and Selection Process.'' (20 points)
    2. The extent to which the conference overall objectives are 
reliable, reasonable, measurable and specific. (15 points)
    3. The extent to which the applicant demonstrates the need for the 
conference. (15 points)
    4. The extent to which high risk populations will ultimately 
benefit from the conference. (15 points)
    5. The extent to which the applicant discusses the potential 
contribution to HIV/AIDS prevention. (10 points)
    6. The extent to which the conference will have potential 
contribution toward the New Initiative: Advancing HIV Prevention. (10 
points)
    7. The extent to which the conference will have potential 
contribution toward the National HIV Prevention Goals based on the CDC 
HIV Prevention Strategic Plan. (10 points)
    8. The extent to which the overall format and organization of the 
LOI meets the format listed in the ``Content and Form of Submission'' 
Section of the Program Announcement. (5 points)
    Application Criteria: You are required to provide measures of 
effectiveness that will demonstrate the accomplishment of the various 
identified objectives of the cooperative agreement. Measures of 
effectiveness must relate to the

[[Page 74588]]

performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    Your application will be evaluated against the following criteria:

    Note: Use the following headings on your application narrative.

    a. Proposed Program and Technical Approach (30 points):
    1. The extent to which the proposed conference description fits one 
of the Funding Preferences listed in ``Section V. Application Review 
Information, Review and Section Process''.
    2. The degree to which the conference objectives are specific, 
measurable, realistic, and time-phased. The extent to which evaluation 
of the conference assesses increased knowledge and attitudes of the 
conference participants.
    3. The relevance and effectiveness of the proposed agenda in 
addressing the conference topic(s).
    4. The degree to which conference activities relate to the 
prevention of HIV.
    b. Applicant Capability and Experience (25 points):
    1. The adequacy of existing resources to administer the program for 
the proposed conference.
    2. The adequacy of existing and proposed facilities for conducting 
conference activities.
    3. The degree to which the applicant has established relationships 
with related government agencies, community planning groups, and 
related community groups. Include letters of support (maximum of five 
letters) from such agencies, addressing related applicant's capability 
and experience. Letters of support must explain how the agency will 
work with the applicant to plan the proposed conference. Letters that 
do not pertain directly to the proposed conference, and specify how the 
agency will work with the applicant, will not be considered.
    c. Qualifications of Program Personnel (25 points):
    1. The qualifications and experience of the principal staff person, 
and his or her ability to devote adequate time to provide effective 
leadership.
    2. Program personnel's ability to accomplish conference objectives.
    3. Key personnel's (including associate staff persons, discussion 
leaders, and speakers) education and expertise relative to the 
conference objectives.
    d. Purpose of the Conference (20 points):
    1. Extent to which the applicant shows that participants and 
presenters will have the opportunity to interact during the conference, 
share information on successful and unsuccessful program experiences, 
and develop collaborative working relationships.
    2. The extent to which the applicant shows the need for the 
conference.
    3. Does the applicant describe non-federal resources for funding at 
least 25 percent of the cost for the conference?
    e. Budget Justification and Adequacy of the Facility (reviewed, but 
not scored):
    The proposed budget will be evaluated on the basis of its 
reasonableness, concise and clear justification, consistency with the 
intended use of cooperative agreement funds, and the extent to which 
the applicant documents financial support from other sources.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by NCHSTP. 
Incomplete applications or applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate your LOI and your 
application according to the criteria listed in the ``V.1. Criteria'' 
section above.
    In addition, the following factors may affect the funding decision:
    Preferences for funding may be given for ensuring a balance of 
funded agencies that:
    1. Serve populations in special settings (e.g., correctional 
institutions, shelters for runaway youth).
    2. Target under-served geographic areas with high-risk populations 
(e.g., migrant and rural populations).
    3. The United States regions and territories are represented.
    4. Target people of color (especially African Americans and 
Hispanic women of color).
    5. Provide support of comprehensive primary and secondary 
prevention programs for persons living with HIV.
    No preference will be given to organizations that have received CDC 
funding in past years.

V.3. Anticipated Announcement Award Date

April 1, 2004

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will be notified by mail of the results of 
the application review.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.

    The following additional requirements apply to this project:
    [sbull] AR-5--HIV Program Review Panel Requirements
    [sbull] AR-8--Public Health System Reporting Requirements
    [sbull] AR-9--Paperwork Reduction Act Requirements
    [sbull] AR-10--Smoke-Free Workplace Requirements
    [sbull] AR-11--Healthy People 2010
    [sbull] AR-12--Lobbying Restrictions
    [sbull] AR-15--Proof of Non-Profit Status
    [sbull] AR-20--Conference Support
    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.


VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    a. Interim performance report, no less than 90 days before the end 
of the budget period. The performance report must include:
    (1) The cooperative agreement number.
    (2) Title of the conference.
    (3) Name of the principal investigator, program director or 
coordinator.
    (4) Name of the organization that conducted the conference.
    (5) A copy of the agenda.
    (6) A list of individuals who participated in the formally planned 
sessions of the meeting.
    (7) A summary of the meeting results, including a discussion of how 
the meeting reached the stated conference objectives.

[[Page 74589]]

    (8) The Program Review Panel's report that all written materials 
have been reviewed as required.
    With the prior approval of CDC, copies of proceedings or 
publications resulting from the conference may be substituted for the 
performance report, provided they contain the information requested in 
items one through eight above.
    b. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    The reports must be sent to the Grants Management Specialist listed 
in ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: (770) 488-2700.
    For program technical assistance, contact: Victoria E. Saho, 
Project Officer, Technical Information and Communications Branch, 
Division of HIV/AIDS Prevention--Intervention Research and Support, 
National Center for HIV, STD and TB Prevention, 1600 Clifton Road, NE, 
M/S E49, Atlanta, GA 30333, Telephone: (404) 639-5211, E-mail: 
vsaho@cdc.gov.
    For business management and budget assistance, contact: Carlos 
Smiley, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-4146, 
Telephone: (770) 488-2722, E-mail: csmiley1@cdc.gov.
    For business management and budget assistance in the territories 
contact: Cynthia Montgomery, Contract Specialist, CDC Procurement and 
Grants Office, 2920 Brandywine Rd., Atlanta, GA 30341-4146, Telephone: 
(770) 488-2632, E-mail: caf5@cdc.gov.

    Dated: December 18, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-31830 Filed 12-22-03; 10:26 am]

BILLING CODE 4163-18-P